SEC Form 4 research
| Issuer | PTC THERAPEUTICS, INC. |
|---|---|
| Tickers | PTCT |
| Reporting owners | 45 |
| Officers and directors | 34 |
| Last public filing | 2026-10-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-09 | Boulding Mark Elliott | S | 192 | $64.26 | Not reported |
| 2026-10-09 | 2026-10-07 | SCHMERTZLER MICHAEL | S | 53 | $63.95 | Not reported |
| 2026-10-09 | 2026-10-07 | SCHMERTZLER MICHAEL | S | 2,447 | $63.38 | Not reported |
| 2026-10-07 | 2026-10-06 | Boulding Mark Elliott | S | 435 | $64.16 | Not reported |
| 2026-10-07 | 2026-10-05 | Boulding Mark Elliott | S | 1,638 | $64.03 | Not reported |
| 2026-10-02 | 2026-09-30 | STEELE GLENN JR MD PHD | S | 12,000 | $65.16 | Not reported |
| 2026-09-18 | 2026-09-17 | SCHMERTZLER MICHAEL | S | 376 | $68.45 | Not reported |
| 2026-09-18 | 2026-09-17 | SCHMERTZLER MICHAEL | S | 9,624 | $67.83 | Not reported |
| 2026-09-18 | 2026-09-16 | SCHMERTZLER MICHAEL | S | 7,006 | $67.35 | Not reported |
| 2026-09-18 | 2026-09-16 | SCHMERTZLER MICHAEL | S | 2,994 | $66.58 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.